Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
Clinical trial NCT03034772 · COMPLETED
Trial details
- NCT number
- NCT03034772
- Sponsor
- Wills Eye
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2019-02-08
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.